A clinical trial to Study the effect of Badaritwakadi Lepa on napkin rash

Open randomized control clinical study of efficacy of Badaritwakadi Lepa on Ahiputana with special reference Napkin Rash

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033839

Enrollment

Registered

2021-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L22- Diaper dermatitis

Interventions

Control Intervention1: Badritwakadi lepa: Badaritwakadi Lepa Dose as per local application Frequency 2 time per day for 5day for External Application Control Intervention2: Bal bhaishjyadi Lepa: Bal b

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children diagnosed as case of Ahiputana with the presenting symptom like Kandu,Ruja,Daha,Pidika at Guda Pradesh 2.children inbetween age of 4 month to 2year

Exclusion criteria

Exclusion criteria: 1.Children above the 2 year and below 4 month 2.children suffering from any other sever systemic disorder e. g acute gastroenteritis with dehydration / heminthes infection 3.childern in NICU AND PICU 4. lactose intolerant

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of badaritwakadi Lepa in AhiputanaTimepoint: 5 day	—

Secondary

Measure	Time frame
To review literature of ahiputanaTimepoint: 4 week	—

Countries

India

Contacts

Public ContactPriyanka Pravin Mohite Patil

Hon.Shri Annasaheb Dange ayurvedic Medical College and Research center Ashta Sangli

dr.nareshbabar@gmail.com7507595454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026